Alpine Immune Sciences to Participate in the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Alpine Immune Sciences (NASDAQ: ALPN) announced its participation in the SVB Securities Global Biopharma Conference on February 16, 2023, at 12:00 p.m. ET. The company will present a corporate overview and host investor meetings. A live webcast will be accessible through the investor relations section of their website, with a 90-day replay afterward. Alpine focuses on developing innovative immunotherapies for autoimmune and inflammatory diseases, leveraging advanced protein engineering technologies. The company aims to create best-in-class multifunctional therapies and has formed strategic collaborations for its clinical and preclinical pipeline.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will present a corporate overview and host investor meetings at the SVB Securities Global Biopharma Conference and present on Thursday, February 16, 2023, at 12:00 p.m. ET/9:00 a.m. PT.

A live webcast of the presentation will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the live event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005742/en/

Media and Investor Contact:

Temre Johnson

Alpine Immune Sciences, Inc.

ir@alpineimmunesciences.com

Source: Alpine Immune Sciences, Inc.

FAQ

What is the date of Alpine Immune Sciences' presentation at the SVB Securities Global Biopharma Conference?

Alpine Immune Sciences will present on February 16, 2023.

What time will Alpine Immune Sciences present at the conference?

The presentation is scheduled for 12:00 p.m. ET / 9:00 a.m. PT.

Where can I watch the Alpine Immune Sciences presentation live?

The live webcast can be accessed through the investor relations section of Alpine's website.

How long will the replay of Alpine Immune Sciences' presentation be available?

The replay will be available for 90 days following the live event.

What is the focus of Alpine Immune Sciences?

Alpine Immune Sciences focuses on developing innovative treatments for autoimmune and inflammatory diseases.